Cancer Clinical Trials in Mexico

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Cancer Clinical Trials in Mexico

Cancer Clinical Trials in Mexico – Top CROs en Latin America

Cancer, a devastating disease that affects millions worldwide, has spurred extensive research and innovation in the field of clinical trials. In Mexico, these trials have become an integral part of the fight against cancer, offering patients hope for improved treatments, breakthrough therapies, and enhanced outcomes.

In this blog, we will delve into the realm of cancer clinical trials in Mexico, exploring their significance, ongoing initiatives, and the potential they hold in transforming cancer care.

The Importance of Cancer Clinical Trials

Clinical trials are pivotal for advancing medical knowledge, refining treatment protocols, and introducing new therapeutic approaches. In the context of cancer, clinical trials play a vital role in evaluating the effectiveness and safety of novel drugs, surgical techniques, radiation therapies, and immunotherapies. They provide an avenue for patients to access cutting-edge treatments and contribute to the collective understanding of cancer.

Mexico’s Commitment to Cancer Clinical Trials

Mexico has made remarkable strides in cancer research, with a growing commitment to conducting clinical trials. The Mexican government, along with academic institutions, hospitals, and pharmaceutical companies, has established a robust infrastructure to facilitate clinical trials and promote collaboration among researchers, clinicians, and patients. This concerted effort aims to expand treatment options, improve patient outcomes, and enhance Mexico’s position in the global oncology research landscape.

Prominent Cancer Clinical Trials in Mexico

Mexico has been actively involved in various cancer clinical trials across multiple therapeutic areas. Some notable trials include the evaluation of targeted therapies for specific cancer types, such as breast, lung, colorectal, and prostate cancers. Additionally, immunotherapy trials utilizing immune checkpoint inhibitors and CAR-T cell therapies have shown promising results in treating hematological malignancies and solid tumors. Mexico’s diverse population and extensive patient pool offer unique opportunities for conducting clinical trials with increased inclusivity and diversity.

Cancer Clinical Trials in Mexico

Cancer Clinical Trials in Mexico

Cancer Clinical Trials in Mexico

Challenges and Opportunities

While cancer clinical trials in Mexico have witnessed significant progress, they also face challenges. Limited awareness among patients, healthcare providers, and the general public about the importance and availability of clinical trials hinders enrollment rates. Additionally, regulatory and logistical hurdles need to be addressed to streamline trial processes further. However, these challenges present opportunities for collaboration, education, and advocacy to increase participation and improve the overall clinical trial landscape.

Advancing Cancer Care: The Future of Clinical Trials in Mexico

The future of cancer clinical trials in Mexico holds tremendous potential. With ongoing efforts to expand research infrastructure, increase patient awareness, and foster international collaborations, Mexico is poised to play an even more significant role in shaping cancer treatment advancements.

The integration of precision medicine, genomic profiling, and novel biomarkers into clinical trials will personalize treatment approaches, leading to improved outcomes and tailored therapies for patients across diverse populations.


Cancer clinical trials in Mexico represent a beacon of hope in the fight against this formidable disease. Through collaboration, investment, and patient engagement, Mexico is actively contributing to global oncology research and transforming cancer care.

By supporting and participating in clinical trials, patients not only gain access to innovative treatments but also become valuable contributors to scientific advancements that will benefit future generations. Together, we can continue to push the boundaries of cancer treatment and bring rays of hope to those affected by this challenging disease.

Cancer Clinical Trials in Mexico

Source: Roche

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Cancer Clinical Trials in Mexico

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Cancer Clinical Trials in Mexico

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Cancer Clinical Trials in Mexico

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Cancer Clinical Trials in Mexico

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Cancer Clinical Trials in Mexico

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Cancer Clinical Trials in Mexico

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Cancer Clinical Trials in Mexico

The Cohortias Team

Cancer Clinical Trials in Mexico

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Cancer Clinical Trials in Mexico

Network & Partnerships